OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers

HTML

Year: 2013
Type: article
Study design: Clinical Trial
Source: Journal of Thoracic Oncology
DOI: 10.1097/jto.0b013e31829923ec
Authors: Jamie E. Chaft, Valerie Rusch, Michelle S. Ginsberg, Paul K. Paik, David J. Finley, Mark G. Kris, Katharine A.R. Price, Christopher G. Azzoli, Matthew G. Fury, Gregory J. Riely, Lee M. Krug, Robert J. Downey, Manjit S. Bains, Camelia S. Sima, Nabil Rizk, William D. Travis, Naiyer A. Rizvi
Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine
Language: English

Topic: Lung Cancer Diagnosis and Treatment
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: bevacizumab, non-small cell lung cancer, non-squamous non-small cell lung cancer, neoadjuvant chemotherapy, cisplatin, docetaxel, pathological downstaging, KRAS mutation, surgical resection, overall survival, biomarkers
SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2019204011
FWCI: 4.236
Cites: 21
Cited by: 129
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security